Description

Cyclobutanecarboxamide, n-(3-Cyano-4-Ethyl-5-Methyl-2-Thienyl)- (9Ci) is a high-purity, advanced pharmaceutical intermediate featuring a unique heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex molecular architectures. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of new drug candidates.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the multi-step synthesis of proprietary drug molecules, especially those targeting central nervous system (CNS) disorders or metabolic diseases.
• Organic Synthesis Building Block: Used in research-scale and process chemistry for constructing complex heterocyclic frameworks containing both cyclobutane and thiophene rings.
• Medicinal Chemistry Research: Employed in structure-activity relationship (SAR) studies and lead optimization programs to develop new chemical entities with potential biological activity.
• Agrochemical Intermediate: Potential application in the development of novel crop protection agents, leveraging its specific functional groups for bioactivity.
• Material Science Research: Investigated as a monomer or specialty additive for creating polymers with unique thermal or optical properties.

Basic Information

Product Name	Cyclobutanecarboxamide, n-(3-Cyano-4-Ethyl-5-Methyl-2-Thienyl)- (9Ci)
CAS No.	444935-17-5
Molecular Formula	C13H16N2OS
Molecular Weight	248.35 g/mol
Synonyms	N-(3-Cyano-4-ethyl-5-methyl-2-thienyl)cyclobutanecarboxamide; 2-Thiophenecarboxamide, N-(3-cyano-4-ethyl-5-methyl-2-thienyl)cyclobutane-; Cyclobutanecarboxamide, N-(3-cyano-4-ethyl-5-methyl-2-thienyl)-; 444935-17-5; UNII-9V6C6107J2; 9V6C6107J2; SCHEMBL23346895; DTXSID90648669
EINECS	Contact for details

Quality Control

Our Cyclobutanecarboxamide, n-(3-Cyano-4-Ethyl-5-Methyl-2-Thienyl)- (9Ci) is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the stringent requirements for pharmaceutical R&D. Certificates of Analysis (COA) detailing batch-specific results are provided and can be tailored to support regulatory filings.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). Keep the container sealed to protect from moisture. Store away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.